The FDA will warn about overuse or misuse of semaglutide (Ozempic, Wegovy and Rybelsus) before the end of 2024.
Plus
27
Ṁ1342Jan 1
19%
chance
1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Get
1,000
and3.00
Sort by:
Related questions
Related questions
What will happen to the GLP-1 / Ozempic compounding pharmacy loophole?
Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by 01/01/2025?
7% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
58% chance
Will Pfizer announce a weight loss drug competing with Ozempic and Wygovy before 12/31/2024?
35% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
33% chance
Will Kim Jong Un start taking Ozempic (or any GLP-1) by the end of 2025?
36% chance
Will Ozempic be FDA approved for use in type 1 diabetes patients by end of 2024?
11% chance
[ACX 2024] Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?
1% chance
When will Hims stop selling semaglutide?
Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?
78% chance